Clinical Trials Browser

Completed × Medulloblastoma × Oxaliplatin × Clear all

NCT00101270 2013-06-05

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Phase 1 Completed

CNSDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Colonic Neoplasms, Medulloblastoma, Melanoma, Nasopharyngeal Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Osteosarcoma, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

NCT00047177 2009-10-15

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Phase 2 Completed

Familial ependymoma, Medulloblastoma, Central Nervous System Neoplasms, Rhabdoid Tumor

NCT00407433 2009-08-07

Clinical Studies of Gemcitabine-Oxaliplatin

Phase 2 Completed

Medulloblastoma, Neuroblastoma, Osteosarcoma, Central Nervous System Neoplasms